Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Opportunities for Cancer Immune Health, Prevention, and Interception

  • Date: Wednesday, September 13, 2023
  • Time: 1:00pm EDT to 2:00pm EDT

Speaker

Robert H. Vonderheide, M.D., D.Phil.

Robert H. Vonderheide, M.D., D.Phil.
Director of the Abramson Cancer Center,
Vice Dean of Cancer Programs, PSOM,
Vice President for Cancer Programs, UPHS
University of Pennsylvania

Robert H. Vonderheide, M.D., D.Phil., is Director of the Abramson Cancer Center, Vice Dean of Cancer Programs for the Perelman School of Medicine, and Vice President for Cancer Programs at the University of Pennsylvania Health System. Dr. Vonderheide is a distinguished laboratory scientist, clinician, and cancer leader who has deciphered mechanisms of cancer immune surveillance and developed novel cancer immunotherapies such as CD40 agonists with a particular focus on pancreatic cancer. He is an expert in the use of genetic mouse models of cancer and a leading architect of immunotherapy clinical trials to understand mechanisms and advance novel therapies. At Penn, Dr. Vonderheide has helped create Penn Medicine’s Immune Health® program for immuno-profiling. Funded by the NCI, SU2C-Lustgarten Foundation, and the Parker Institute, Dr. Vonderheide has published senior author manuscripts in Nature, Nature Medicine, Science, Lancet Oncology, and the New England Journal of Medicine. Nationally, Dr. Vonderheide is an elected member of ASCI and AAP, serves on the NCI Board of Scientific Advisers, is a member of the boards of directors for American Association of Cancer Research, American Association of Cancer Institutes, and National Comprehensive Cancer Network.

Point of Contact

Contact Person: Altaf Mohammed
Contact Email: altaf.mohammed@nih.gov